Informação da revista
Vol. 37. Núm. 1.
Páginas 77-85 (janeiro 2018)
Baixar PDF
Mais opções do artigo
Vol. 37. Núm. 1.
Páginas 77-85 (janeiro 2018)
Review Article
Open Access
Coronary artery disease in athletes: An adverse effect of intense exercise?
Doença coronária em atletas: «efeito adverso do exercício físico intenso?»
Hélder Doresa,b,c,d,
Autor para correspondência

Corresponding author.
, Pedro de Araújo Gonçalvesb,c,d,e, Nuno Cardimb,c, Nuno Neuparthc,d
a Hospital das Forças Armadas, Lisbon, Portugal
b Hospital da Luz, Lisbon, Portugal
c NOVA Medical School, Lisbon, Portugal
d CEDOC (Chronic Diseases Research Center), NOVA Medical School, Lisbon, Portugal
e Hospital de Santa Cruz, CHLO, Lisbon, Portugal
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Baixar PDF
Figuras (7)
Mostrar maisMostrar menos

Regular physical exercise is responsible for various health benefits, and is recommended for primary and secondary cardiovascular (CV) prevention. Despite these recognized benefits, various clinical events can occur in athletes, including acute myocardial infarction and sudden cardiac death (SCD); the main cause of SCD in veteran athletes is coronary artery disease (CAD). The relationship between intense exercise training and CAD is controversial, and a U-shaped association has been hypothesized. If this is the case, screening for subclinical CAD in older athletes may be justified, and various different methodologies have been proposed. However, the methodology for screening veteran athletes is not consensual, and several markers of CAD, in addition to clinical CV risk factors, could improve risk stratification in this population. In the present paper we review the published data on CAD in athletes, focusing on the relationship between the dose of exercise and CAD, as well as the implications for pre-participation screening of veteran athletes.

Veteran athletes
Dose of exercise
Coronary artery disease
Coronary computed tomography angiography

O exercício físico associa-se a múltiplos benefícios para a saúde, estando recomendado na prevenção cardiovascular (CV) primária e secundária. Apesar dos benefícios comprovados, diversos eventos clínicos podem ocorrer em atletas, incluindo enfarte agudo do miocárdio e morte súbita, nos atletas veteranos maioritariamente devido a doença das artérias coronárias (DAC). A relação entre exercício físico intenso e DAC permanece controversa, colocando-se a hipótese de associação tipo «curva em U». Neste contexto, a deteção subclínica de DAC em atletas veteranos pode ser justificada, estando propostas algumas metodologias. No entanto, a metodologia para a avaliação pré-competitiva dos atletas veteranos não é consensual e diversos marcadores de risco, adicionais aos fatores de risco CV clínicos tradicionais, poderão melhorar a estratificação de risco nesta população. Neste artigo revêm-se os dados publicados sobre DAC em atletas, com relevância para a relação entre a dose de exercício e DAC, bem como as implicações para a avaliação pré-competitiva de atletas veteranos.

Atletas veteranos
Dose de exercício
Doença das artérias coronárias
Angiografia coronária por tomografia computorizada
Texto Completo

Regular physical activity and exercise training have various health benefits, and are recommended for primary and secondary cardiovascular (CV) prevention.1,2 The benefits of exercise are mediated by multiple mechanisms, with favorable impact both in the general population and in patients with established CV disease in the context of cardiac rehabilitation. Among these effects are the prevention and control of various CV risk factors, including reduction in the incidence of obesity and diabetes and improved lipid and blood pressure profiles, as well as reduction of acute coronary events and increased survival.2

In response to the constant campaigns promoting the benefits of physical activity and exercise training, the number of people participating regularly in sports has grown in recent decades. Consequently, the spectrum of athletes has widened to include not only young adults, but also children and the elderly, with more individuals taking up regular exercise in middle age and continuing until late in life. Evidence of this tendency is the large number of veteran athletes involved in high dynamic component disciplines such as cycling, marathon, triathlon and Ironman races.3,4

Although much is now known about exercise-induced physiological cardiac adaptations, the long-term effects of prolonged and excessive intense exercise training remain unclear. Recent evidence points to a potential U-shaped relationship between the dose of exercise and the occurrence of clinical CV events, which could be related to the presence and severity of coronary artery disease (CAD). This is an important issue, since CAD is responsible for the greatest proportion (approximately 80%) of sudden cardiac death (SCD) in veteran athletes, a less studied athletic population.

The recent development of new CV imaging tests, including non-enhanced cardiac computed tomography (CT) with calcium scoring (CS) and enhanced cardiac CT (coronary CT angiography [CCTA]), has enabled non-invasive detection and better characterization of the presence and severity of CAD.5 This could be a game-changer for risk stratification in veteran athletes, changing the paradigm from traditional stratification based on clinical CV risk factors and exercise electrocardiographic testing, which has well-known limitations.6

In the present paper we review the published data on CAD in athletes, focusing on the relationship between the dose of exercise and CAD, the potential mechanisms involved and the implications for pre-participation screening of veteran athletes, highlighting the role of CS and CCTA.

The paradox of sudden cardiac death in athletes

Despite the proven benefits of regular physical exercise and although athletes are the paradigm of healthy individuals, this population is not risk-free and can suffer severe clinical conditions including SCD.5,7 Although SCD is uncommon in young athletes (incidence 2-5/100000 per year), it is a tragic event, with high visibility due to media attention. Most sports-related cardiac arrests occur in individuals not performing regular exercise, and in epidemiological terms, SCD during sports accounts for only a small proportion of cases in the general population.

Several studies have confirmed both the increased risk of exercise-associated myocardial infarction and SCD and the beneficial effect of regular exercise in risk reduction. Data from Italy revealed a 2.8-fold greater risk of SCD in young competitive athletes compared to non-athletes.8 However, it should be stressed that exercise is not the cause of death, but is a precipitating factor in susceptible individuals with previously undiagnosed cardiac disease. It should also be recognized that the overall beneficial effects of exercise in the population outweigh the increased risk.

In young athletes the most common causes of SCD are hereditary diseases, mainly cardiomyopathies and primary arrhythmic diseases, while in veteran athletes the great majority is caused by CAD.5,9–12 For the purpose of this paper, we define a veteran athlete as an individual more than 35 years old participating in sports at a competitive level or as a leisure activity. The majority of sports-related SCD occurs in older athletes, but as many of the deaths are unwitnessed, the magnitude of the problem is probably underestimated.12 Beyond the difference in the athletes’ age, other important epidemiological features of SCD in athletes are the higher frequency in males (9:1 to females) and occurrence during or immediately after exercise and mainly in high dynamic component sports.5

Identification of athletes with higher CV risk is a crucial goal of pre-participation screening.13,14 Although controversial, due to the long-standing disagreement between Europe and the US, the methodology recommended by the European Society of Cardiology (ESC) for screening of young athletes includes medical history (personal and family), physical examination, and 12-lead electrocardiogram (ECG).13 Central to the disagreement is the ECG, due to the high rate of false positive results. The main question is not whether the ECG should be included, but how it should be interpreted; the adoption of more restrictive criteria decreases the false-positive rate without reducing sensitivity and with a favorable impact on cost-effectiveness.15–19 Regarding the pre-participation screening of veteran athletes the controversy is greater, as will be discussed below.

Coronary artery disease in athletes

SCD or acute myocardial infarction may be the first clinical presentation of CAD. The rupture of non-obstructive coronary plaques is the most common pathophysiological mechanism involved, which explains the previous absence of symptoms such as angina, usually present in individuals with obstructive CAD.9,20,21 Superficial plaque erosion and intraplaque hemorrhage are other mechanisms associated with coronary plaque instability, but ischemia due to an imbalance between oxygen supply and demand has also been described as one of the main causes of acute exercise-related cardiac arrest.20

Plaque rupture during exertion typically occurs in the central part of a thin fibrous cap with numerous vasa vasorum, while plaque rupture at rest occurs more in the periphery, at the junction between the fibrous cap and the arterial wall (Figure 1).12,22

Figure 1.

Comparison between coronary plaque rupture with exertion and at rest (reprinted from Burke et al.22). HP: hemorrhage into plaque; L: lumen; Th: thrombus.


Although the concept of advanced atherosclerosis in veteran athletes is somewhat counter-intuitive, various stress factors and pathophysiological mechanisms induced by chronic and extreme endurance exercise may play a critical role.

Among the potential mechanisms triggering exertion-related acute coronary syndromes are increased thrombogenicity, sympathetic activation, electrolyte imbalance, hyperdynamic circulation, shear stress and imbalance between the antioxidative and oxidative effects of exercise.12 An analysis performed in men with CAD exposed to physical exercise showed an improvement in antioxidant and vascular effects, a benefit which can be blunted with increased exercise intensity.23 Intense and prolonged exercise increases oxidative stress and release of inflammatory mediators such as oxygen free radicals and cytokines, a process documented in patients with CAD. Beyond the potential involvement of these exercise-related factors, it should be borne in mind that, as in the general population, the development of CAD in athletes is multifactorial, and can be affected by clinical CV risk factors, genetic predisposition, normal aging processes, infections and toxins (Figure 2).

Figure 2.

Factors potentially involved in the development of coronary artery disease in athletes. CV: cardiovascular.


Exercise training leads to the release of cardiac biomarkers, particularly troponin, an invaluable tool for the assessment of patients with myocardial infarction. In the context of exertion, this appears to be a benign process, but the underlying mechanisms are still poorly understood. Troponin elevation is likely to result from increased myocyte turnover, cellular release of proteolytic troponin degradation products, cellular wall permeability and formation and release of membranous blebs.24–26 Interestingly, the extent of troponin release is strongly related to intensity of exercise, and it is not clear if recurrent episodes would lead to long-term adverse cardiac effects.

Even with lower incidences, it is important to emphasize that besides the atherosclerotic process, there are other coronary abnormalities associated with SCD in athletes that should be considered and excluded, such as anomalous coronary artery origin, vasospasm, bridging, coronary dissection and vasculitis, which are beyond the scope of the present review.27,28

Relationship between amount of exercise and coronary artery disease

The relationship between amount of exercise and CAD is still not well established. In principle, as a drug becomes ineffective at a dose below that recommended, or toxic in the case of overdose, the same could happen with physical exercise. It is known that relatively modest doses of regular exercise are sufficient to induce benefits, but the upper limit above which the adverse effects outweigh the benefits has not been determined.29–32 There is emerging evidence that with increasing doses of exercise, the relative benefits decrease.30 Humans may not be genetically adapted for sustained intense exercise, and if so, it is worth considering how much exercise could actually be harmful and what the desired therapeutic window of exercise would be.

Extreme exercise leads to various cardiac changes (histological, structural and functional). These are mainly physiological adaptations, but maladaptation can also occur, increasing susceptibility to atrial and ventricular arrhythmias. Myocardial fibrosis, inflammation, marked ventricular remodeling and accumulation of coronary calcium are potentially related to extreme exercise (Figure 3).

Figure 3.

Potential cardiovascular effects of regular intense exercise training. ARVC: arrhythmogenic right ventricular cardiomyopathy; CAD: coronary artery disease; CV: cardiovascular; SCD: sudden cardiac death.


Some authors have argued that there exists a type of cardiotoxicity induced by extreme exercise, and the relationship between dose of exercise and incidence of clinical events has been described as a U-shaped curve.33,34 Moderate exercise appears to be better than none, but vigorous exercise may actually be harmful, at least for some individuals. From a public health perspective, we emphasize that although these findings raise some concerns about the benefits of high-end endurance sports, they do not undermine the substantial beneficial effects of regular exercise on all-cause mortality in the vast majority of older athletes.

Regarding mortality, this U-shaped relationship is clear for running distances, speeds and frequencies.35 In the Copenhagen City Heart Study,36 moderate joggers had lower mortality than sedentary nonjoggers and strenuous joggers. Although the evidence is weaker, the same relationship has been proposed for the presence and severity of CAD (Figure 4). In fact, the dose of exercise has a central role, as most cardiac arrests during marathons occur in the last quartile of races, although this could also be explained by cumulative electrolyte disturbances during the race.37

Figure 4.

Hypothetical representation of the relationship between the dose of exercise and the incidence and severity of coronary artery disease. CAD: coronary artery disease.


In daily clinical practice, it is not uncommon to identify athletes with a higher than expected atherosclerotic burden. Figure 5 illustrates a CCTA of an asymptomatic 47-year-old male competitive Ironman athlete, with a discrepancy between total CV risk based on SCORE (<1%) and extent of CAD.38

Figure 5.

Coronary computed tomography angiography of a competitive Ironman veteran athlete with low cardiovascular risk based on SCORE (<1%), but with a higher than expected atherosclerotic burden (calcium score >percentile 90), with plaques in all the epicardial coronaries, including >5 segments with plaque (segment involvement score >5) and involvement of the left main and proximal left anterior descending arteries (adapted from Dores et al.38).


The potential association between intense exercise training and CAD does not appear to be an incidental finding. In recent years, several authors have described a higher than expected CAD incidence and severity in veteran athletes involved in endurance sports. Mohlenkamp et al.39 studied 108 veterans who ran at least five marathons over the previous three years, compared with a control group of non-athletes. CS was similar in both groups with adjustment for age, but significantly higher in the athletes after adjustment for Framingham risk score (mean CS: 36 vs. 12, p=0.02; CS ≥100: 36% vs. 22%, p=0.01; CS >percentile 75: 25% vs. 15%, p=0.01). During a mean follow-up of 21 months, athletes with CS ≥100 had a higher rate of CV events. Tsiflikas et al.40 studied male marathoners aged over 45 years and detected CAD in half of them, including 24% with plaques in the proximal coronary segments. Merghani et al.41 documented a U-shaped curve for the relationship between dose of exercise and CS in veteran athletes. A CS >percentile 70 was two or three times more frequent in athletes training >30 miles/week vs. <20 miles/week (39% vs. 13%; p=0.037). In the recent published MARC study,42 CCTA detected occult CAD in almost one in five asymptomatic sportsmen aged ≥45 years after a normal sports medical evaluation that included resting and exercise ECG. The number needed to treat in order to prevent one CV event compares favorably to that of other screening tests.

Despite these findings, several questions remain unanswered. These results imply that endurance athletes may not be protected from accumulation of coronary calcium, but it is important to recognize that the evidence does not show that endurance athletics has an adverse impact on either CS or CV events.12 It should also be emphasized that as well as being few in number, the published studies show inconsistencies: different inclusion criteria, regular exercise training begun at different ages, small samples, and different characterizations of exercise training.43 This issue requires a thorough analysis and more evidence, and is an emerging area of research in sports cardiology.

Cardiovascular risk stratification of veteran athletes

The epidemiological differences between young and veteran athletes justify the adoption of different pre-participation screening methodologies in the two groups. The large number of middle-aged individuals engaged in leisure-time sports makes the screening of this population an emerging task. Although the main cause of SCD in veteran athletes is coronary events, the focus of this screening should rule out subclinical CAD.12,44 Currently, a stepwise approach is suggested for the assessment of middle-aged/senior individuals involved in leisure or competitive sports:

  • Step 1: Self-assessment using pre-specified questionnaires;

  • Step 2: Assessment by a physician (personal and family history, physical examination, SCORE calculation and resting ECG);

  • Step 3: Maximal exercise testing.

The identification and management of CAD in asymptomatic individuals (athletes or non-athletes) is a difficult task and there is still no agreement on the correct approach to adopt.45 Total risk estimation using multiple risk factors is recommended by the ESC for asymptomatic adults without evidence of CV disease (class I, level of evidence C).2 However, the predictive capacity of this conventional methodology based on clinical scores such as the Framingham risk score and SCORE is modest, failing to identify a significant proportion of individuals with established CAD. If these scores had been calculated on the day before an acute myocardial infarction, most patients would have had low-moderate risk, without indication for the implementation of preventive or therapeutic measures.46–48

Regarding the CV assessment of middle-aged/senior individuals engaged in leisure-time sports, the ESC recommends self-assessment of habitual physical activity level and risk factors, followed by SCORE calculation. Individuals with an increased risk for coronary events embarking on moderate/intense physical activity should undergo a maximal exercise test and possibly further cardiac investigation.49 Although this methodology may be valid in veteran athletes, it does not take into consideration specific characteristics such as dose of exercise, type of sport and length of exercise training. It seems obvious that more intensive investigation should be performed in athletes with moderate-high CV risk, particularly for those who are naïve or involved in high-level endurance sports. The main question is which further investigations should be performed.

Despite its recognized prognostic value, the utility of the ECG for screening asymptomatic subjects without known CAD is limited. Up to half of individuals with angiographically normal coronary arteries show changes on the ECG, one-third of those with CAD have normal baseline ECG, and the majority of coronary events occur in the absence of prior electrocardiographic abnormalities. In addition, all stress tests, by definition, depend on the presence of obstructive CAD and therefore they are not designed to detect nonobstructive CAD, which has been associated with worse CV outcome in several CCTA studies.50–54

Usually, athletes with high CV risk undergo an exercise ECG test, an exam of established prognostic value, widespread availability and low cost. Several studies have reported an increased relative risk of coronary death for asymptomatic subjects with a positive test. However, the accuracy of exercise testing for CAD detection in populations with low pretest probability, such as asymptomatic athletes involved in high-intensity sports, is limited.55–57 To overcome some of these limitations the measurement of biomarkers (e.g. high-sensitivity C-reactive protein and natriuretic peptides) has been proposed, but the gain in CAD detection and the practical applicability were low.58,59

Apart from the conventional scores based on clinical risk factors, it is known that some risk modifiers detected by emerging tests such as CS and carotid atherosclerotic plaque detection can improve the calculation of total CV risk.

The role of calcium score and cardiac computed tomography in screening veteran athletes

Determination of total atherosclerotic burden is an option for screening veteran athletes, helping to detect coronary calcifications, a recognized marker of subclinical atherosclerosis. CS is a non-invasive marker of CAD with proven prognostic impact, predicting CV events and death, independently of and incremental to conventional risk factors.60–63 CS is a risk modifier that can be considered in individuals with SCORE around 5%-10%. In the PESA study64 in individuals aged 40-54 years, 63% had subclinical atherosclerosis after assessment of multivascular territories, and CAD was detected in 18% of individuals, most of them with low SCORE. The landmark MESA study65 showed superior discrimination and reclassification of CV risk in intermediate-risk individuals using subclinical markers. CS had higher predictive power than other markers such as carotid intima-media thickness and ankle-brachial index, in agreement with the results of the Rotterdam study.66 Additionally, CS improves the adoption of preventive measures, leading to better control of several CV risk factors, as shown in the EISNER study.67,68

It is important to stress that not all coronary plaques are calcified, nor is CS an indicator of plaque instability. Moreover, although much less frequent than calcified or mixed plaques, non-calcified plaques are more prone to instability leading to acute coronary events. In this context, CCTA provides useful additional information, enabling better characterization of the coronary tree and plaques.26,69 Beyond obstructive CAD, the presence and quantity of non-obstructive plaques also has prognostic value, as shown in the CONFIRM registry70 and in other CCTA studies using atherosclerotic burden indices like the segment involvement score53 or the CT-adapted Leaman score (CT-LeSc).54 The comprehensive information provided by CCTA, including location, type and number of plaques, can be clustered in CCTA atherosclerotic burden scores like the CT-LeSc,71 which can help identify individuals with nonobstructive CAD at higher risk of CV events and therefore contribute to risk stratification.54

A recent study by Ermolao et al.57 in asymptomatic middle-aged athletes with ST-segment anomalies during maximal exercise test (diagnostic or equivocal) revealed CAD in only 32% of the subjects. In the MARC study,42 in 318 middle-aged sportsmen with low SCORE who underwent CCTA following normal pre-participation screening, 94% had low CV risk and 18.9% had CAD (CS ≥100 or ≥50% luminal stenosis), almost one in five individuals. In this setting, some authors have proposed the inclusion of CCTA in the screening of veteran endurance athletes with moderate-high CV risk. However, as Braber et al.42 showed, even veteran athletes with low CV risk could benefit from CCTA, increasing the controversy concerning the target population of this exam. Based on these data, mainly derived from studies performed in athletes aged >40 years involved in endurance sports and with a wide spectrum of CV risk (including low risk), a hypothetical flowchart for veteran athletes screening is proposed in Figure 6.

Figure 6.

Algorithm proposed for veteran athlete screening. CAD: coronary artery disease; CCTA: coronary computed tomography angiography; CT-LeSc: computed tomography-adapted Leaman score; CV: cardiovascular; ECG: electrocardiogram; SIS: segment involvement score.


Another important feature of CCTA is the ability to detect other important coronary abnormalities in the screening of athletes, such as malignant variants of anomalous origin of the coronaries and coronary bridging, both described as possible causes of SCD in athletes.

In addition, and also of considerable importance, recent technological developments in scanner technology (both hardware and software) have led to impressive reductions in radiation dose, the main limitation of CCTA.72,73Figure 7 presents an example of a CCTA performed with a new-generation scanner, showing high image quality with ultra-low radiation and contrast doses (0.5 mSv and 50 cc, respectively).

Figure 7.

Coronary computed tomography angiography of a non-competitive athlete performed with a new-generation scanner (SOMATOM Force, Siemens Healthcare), using an ultra-low radiation dose of 0.5 mSv. Left: volume rendering technique images and study protocol; middle: nonobstructive mixed plaque in the proximal segment of the right coronary artery; right: nonobstructive calcified plaque in the proximal left anterior descending artery. LAD: left anterior descending artery; RCA: right coronary artery.


Finally, although we have reviewed the published evidence linking physical exercise and the presence and severity of CAD, several issues remain unanswered and warrant further research. It is the view of the authors that although CV risk stratification of veteran athletes is at present still based on traditional risk factors and rest ECG, cardiac CT may play a role in the future. To clarify this important issue, further research is needed focusing on three lines of investigation: first, to explore the possible U-shaped association between the dose of exercise and CAD; second, to establish the added value of CS and CCTA in screening of veteran athletes; and third, to demonstrate that the use of these newer CT-based imaging modalities can further improve risk stratification of this important subset of presumed healthy individuals, who may in fact be at risk of CV events.


The benefits of exercise in the overall population are indisputable, but in athletes with CV disease exercise can also be associated with adverse clinical events, including SCD. In veterans, a growing group of athletes, CAD is the most common cause of SCD, and there appears to be an U-shaped relationship with the dose of exercise. Detection of subclinical CAD should be the main objective of veteran athlete screening, since the performance of classical CV risk stratification based on clinical factors appears to be suboptimal. Emerging data show an important role for CS and CCTA in this setting. Coupled with the impressive technical improvements in scanner technology in recent years, these have the potential to make cardiac CT a game-changer in the risk stratification of veteran athletes, with the ultimate goal of reducing the burden of CV events in this population, and should be the focus of further investigation in the near future.

P. Thompson.
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology.
Arterioscler Thromb Vasc Biol, 23 (2003), pp. 42-49
M.F. Piepoli, A.W. Hoes, S. Agewall, et al.
2016 European Guidelines on cardiovascular disease prevention in clinical practice.
Eur Heart J, 37 (2016), pp. 2315-2381
B. Knechtle, P. Knechtle, R. Lepers.
Participation and performance trends in ultra-triathlons from 1985 to 2009.
Scand J Med Sci Sports, 21 (2011), pp. 82-90
2014 Running USA Annual Marathon Report | Running USA. Available at: [cited 23.02.16].
N. Chandra, R. Bastiaenen, M. Papadakis, et al.
Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas.
J Am Coll Cardiol, 61 (2013), pp. 1027-1040
H. Dores, P. de Araújo Gonçalves, A.M. Ferreira, et al.
Performance of traditional risk factors in identifying a higher than expected coronary atherosclerotic burden.
Rev Port Cardiol, 34 (2015), pp. 247-253
C.E. Lawless, B. Olshansky, R.L. Washington, et al.
Sports and exercise cardiology in the United States: cardiovascular specialists as members of the athlete healthcare team.
J Am Coll Cardiol, 63 (2014), pp. 1461-1472
D. Corrado, C. Basso, A. Pavei, et al.
Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program.
JAMA, 296 (2006), pp. 1593-1601
M.W. Parker, P.D. Thompson.
Assessment and management of atherosclerosis in the athletic patient.
Prog Cardiovasc Dis, 54 (2012), pp. 416-422
B.J. Maron, J. Shirani, L.C. Poliac, et al.
Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.
JAMA, 276 (1996), pp. 199-204
B.J. Maron.
Sudden death in young athletes.
N Engl J Med, 349 (2003), pp. 1064-1075
S.S. Chugh, J.B. Weiss.
Sudden cardiac death in the older athlete.
J Am Coll Cardiol, 65 (2015), pp. 493-502
D. Corrado, A. Pelliccia, H.H. Bjørnstad, et al.
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol – Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
Eur Heart J, 26 (2005), pp. 516-524
Y.L. Rooks, G.P. Matherne, J. Whitehead, et al.
Protecting the heart of the American athlete: proceedings of the American College of Cardiology Sports and Exercise Cardiology Think Tank October 18, 2012, Washington, DC.
J Am Coll Cardiol, 64 (2014), pp. 2146-2171
K.G. Harmon, M. Zigman, J.A. Drezner.
The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: a systematic review/meta-analysis.
J Electrocardiol, 48 (2015), pp. 329-338
D. Corrado, A. Pelliccia, H. Heidbuchel, et al.
Recommendations for interpretation of 12-lead electrocardiogram in the athlete.
Eur Heart J, 31 (2010), pp. 243-259
J.A. Drezner, M.J. Ackerman, J. Anderson, et al.
Electrocardiographic interpretation in athletes: the ‘Seattle Criteria’.
Br J Sports Med, 47 (2013), pp. 122-124
N. Sheikh, M. Papadakis, S. Ghani, et al.
Comparison of electrocardiographic criteria for the detection of cardiac abnormalities in elite black and white athletes.
Circulation, 129 (2014), pp. 1637-1649
H. Dhutia, A. Malhotra, V. Gabus, et al.
Cost implications of using different ECG criteria for screening young athletes in the United Kingdom.
J Am Coll Cardiol, 68 (2016), pp. 702-711
P. Libby.
Mechanisms of acute coronary syndromes and their implications for therapy.
N Engl J Med, 368 (2013), pp. 2004-2013
P. De Araújo Gonçalves, J. Brito, P.J. Sousa, et al.
Nonobstructive coronary disease leading to STEMI: assessment of residual stenosis after thrombus aspiration.
Coron Artery Dis, 24 (2013), pp. 154-159
A.P. Burke, A. Farb, G.T. Malcom, et al.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
JAMA, 28 (1999), pp. 921-926
A.P. Michaelides, D. Soulis, C. Antoniades, et al.
Exercise duration as a determinant of vascular function and antioxidant balance in patients with coronary artery disease.
Heart, 97 (2011), pp. 832-837
R. Shave, A. Baggish, K. George, et al.
Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications.
J Am Coll Cardiol, 56 (2010), pp. 169-176
J. Scherr, S. Braun, T. Schuster, et al.
72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon.
Med Sci Sports Exerc, 43 (2011), pp. 1819-1827
E. Karlstedt, A. Chelvanathan, M. Da Silva, et al.
The impact of repeated marathon running on cardiovascular function in the aging population.
J Cardiovasc Magn Reson, 14 (2012), pp. 58
B.J. Maron, J.J. Doerer, T.S. Haas, et al.
Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.
Circulation, 119 (2009), pp. 1085-1092
B.D. Levine.
Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 8: coronary artery disease: a scientific statement from the American Heart Association and American College of Cardiology.
J Am Coll Cardiol, m (2015), pp. 2350-2355
C.P. Wen, J.P.M. Wai, M.K. Tsai, et al.
Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study.
Lancet, 378 (2011), pp. 1244-1253
T.M.H. Eijsvogels, S. Molossi, D. Lee, et al.
Exercise at the extremes.
J Am Coll Cardiol, 67 (2016), pp. 316-329
D.I. Feldman, M.H. Al-Mallah, S.J. Keteyian, et al.
No evidence of an upper threshold for mortality benefit at high levels of cardiorespiratory fitness.
J Am Coll Cardiol, 65 (2015), pp. 629-630
J.H. O’Keefe, H.R. Patil, C.J. Lavie, et al.
Potential adverse cardiovascular effects from excessive endurance exercise.
Mayo Clin Proc, 87 (2012), pp. 587-595
J.H. O’Keefe, C.J. Lavie.
Run for your life … at a comfortable speed and not too far.
A. Merghani, A. Malhotra, S. Sharma.
The U-shaped relationship between exercise and cardiac morbidity.
Trends Cardiovasc Med, (2015), pp. 1-9
D.C. Lee, R.R. Pate, C.J. Lavie, et al.
Running and all-cause mortality risk – is more better?.
Med Sci Sports Exerc, 44 (2012), pp. S699
P. Schnohr, J.H. O’Keefe, J.L. Marott, et al.
Dose of jogging and long-term mortality: the Copenhagen City Heart Study.
J Am Coll Cardiol, 65 (2015), pp. 411-419
J.H. Kim, R. Malhotra, G. Chiampas, et al.
Cardiac arrest during long-distance running races.
N Engl J Med, 366 (2012), pp. 130-140
H. Dores, P. De Araújo Gonçalves, M.S. Carvalho, et al.
Doença coronária não obstrutiva documentada por tomografia computorizada cardíaca: contraste entre a carga aterosclerótica e o risco cardiovascular.
Rev Port Cardiol, 32 (2013), pp. 613-618
S. Mohlenkamp, N. Lehmann, F. Breuckmann, et al.
Running: the risk of coronary events – prevalence and prognostic relevance of coronary atherosclerosis in marathon runners.
Eur Heart J, 29 (2008), pp. 1903-1910
I. Tsiflikas, C. Thomas, C. Fallmann, et al.
Prevalence of subclinical coronary artery disease in middle-aged, male marathon runners detected by cardiac CT.
Rofo, 187 (2015), pp. 561-568
T.L. Braber, A. Mosterd, N.H. Prakken, et al.
Occult coronary artery disease in middle-aged sportsmen with a low cardiovascular risk score: the Measuring Athlete's Risk of Cardiovascular Events (MARC) study.
Eur J Prev Cardiol, 23 (2016), pp. 1677-1684
A. La Gerche, H. Heidbuchel.
Response to Levine.
Circulation, 130 (2014), pp. 991
D. Corrado, C. Schmied, C. Basso, et al.
Risk of sports: do we need a pre-participation screening for competitive and leisure athletes?.
Eur Heart J, 32 (2011), pp. 934-944
P.D. Thompson, B.A. Franklin, G.J. Balady, American Heart Association Council on Nutrition, Physical Activity, and Metabolism; American Heart Association Council on Clinical Cardiology; American College of Sports Medicine, et al.
Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology.
Circulation, 115 (2007), pp. 2358-2368
M.J. Blaha, M.G. Silverman, M.J. Budoff.
Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease? Clinical risk scores are not sufficient to define primary prevention treatment strategies among asymptomatic patients.
Circ Cardiovasc Imaging, 7 (2014), pp. 398-408
M.J. Pletcher, C.T. Sibley, M. Pignone, et al.
Interpretation of the coronary artery calcium score in combination with conventional cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA).
Circulation, 128 (2013), pp. 1076-1084
S. Yusuf, S. Hawken, S. Ôunpuu, et al.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries in a case-control study based on the INTERHEART study.
M. Borjesson, A. Urhausen, E. Kouidi, et al.
Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation.
Eur J Cardiovasc Prev Rehabil, 18 (2011), pp. 446-458
G. Rose, P.J. Baxter, D.D. Reid, et al.
Prevalence and prognosis of electrocardiographic findings in middle-aged men.
Br Heart J, 40 (1978), pp. 636-643
D.S. Siscovick, L.G. Ekelund, J.L. Johnson, et al.
Sensitivity of exercise electrocardiography for acute cardiac events during moderate and strenuous physical activity. The Lipid Research Clinics Coronary Primary Prevention Trial.
Arch Intern Med, 151 (1991), pp. 325-330
J.K. Min, A. Dunning, F.Y. Lin, et al.
Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings.
J Am Coll Cardiol, 58 (2011), pp. 849-860
M.S. Bittencourt, E. Hulten, B. Ghoshhaira, et al.
Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events.
Circ Cardiovasc Imaging, 7 (2014), pp. 282-291
S. Mushtaq, De Araujo Gonçalves, H.M. Garcia-Garcia, et al.
Long-term prognostic effect of coronary atherosclerotic burden: validation of the computed tomography-Leaman score.
Circ Cardiovasc Imaging, 8 (2015), pp. e002332
G. Montalescot, U. Sechtem, S. Achenbach, et al.
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Eur Heart J, 34 (2013), pp. 2949-3003
R. Gianrossi, R. Detrano, D. Mulvihill, et al.
Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis.
Circulation, 80 (1998), pp. 87-98
A. Ermolao, F. Roman, A. Gasperetti, et al.
Coronary CT angiography in asymptomatic middle-aged athletes with ST segment anomalies during maximal exercise test.
Scand J Med Sports, 1 (2016), pp. 57-63
O. Melander, C. Newton-Cheh, P. Almgren, et al.
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
JAMA, 302 (2009), pp. 49-57
R.K. Upadhyay.
Emerging risk biomarkers in cardiovascular diseases and disorders.
J Lipids, 2015 (2015), pp. 971453
M.J. Budoff, K.M. Gul.
Expert review on coronary calcium.
Vasc Health Risk Manag, 4 (2008), pp. 315-324
P. Greenland, R.O. Bonow, B.H. Brundage, et al.
ACCF/AHA 2007 Clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain.
J Am Coll Cardiol, 49 (2007), pp. 378-402
M.J. Budoff, L.J. Shaw, S.T. Liu, et al.
Long-term prognosis associated with coronary calcification. Observations from a registry of 25,253 patients.
J Am Coll Cardiol, 49 (2007), pp. 1860-1870
P. Raggi, T.Q. Callister, B. Cooil, et al.
Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography.
Circulation, 101 (2000), pp. 850-855
L. Fernández-Friera, J.L. Peñalvo, A. Fernández-Ortiz, et al.
Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (Progression of Early Subclinical Atherosclerosis) study.
Circulation, 131 (2015), pp. 2104-2113
J. Yeboah, R.L. McClelland, T.S. Polonsky, et al.
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
JAMA, 308 (2012), pp. 788-795
M. Kavousi, S. Elias-Smale, J.H.W. Rutten, et al.
Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.
Ann Intern Med, 156 (2012), pp. 438-444
A. Pen, Y. Yam, L. Chen, et al.
Discordance between Framingham Risk Score and atherosclerotic plaque burden.
Eur Heart J, 34 (2013), pp. 1075-1082
A. Rozanski, H. Gransar, L.J. Shaw, et al.
Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial.
J Am Coll Cardiol, 57 (2011), pp. 1622-1632
M. Hadamitzky, S. Täubert, S. Deseive, et al.
Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease.
Eur Heart J, 34 (2013), pp. 3277-3285
M. Hadamitzky, S. Achenbach, M. Al-Mallah, et al.
Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT angiography evaluation for clinical outcomes: an international multicenter registry).
J Am Coll Cardiol, 62 (2013), pp. 468-476
P. De Araújo Gonçalves, H.M. Garcia-Garcia, H. Dores, et al.
Coronary computed tomography angiography-adapted Leaman score as a tool to noninvasively quantify total coronary atherosclerotic burden.
Int J Cardiovasc Imaging, 29 (2013), pp. 1575-1584
S.S. Halliburton, S. Abbara, M.Y. Chen, et al.
SCCT guidelines on radiation dose and dose-optimization strategies in cardiovascular CT.
J Cardiovasc Comput Tomogr, 5 (2012), pp. 198-224
P. De Araújo Gonçalves, P.J. Sousa, R. Calé, et al.
Effective radiation dose of three diagnostic tests in cardiology: single photon emission computed tomography, invasive coronary angiography and cardiac computed tomography angiography.
Rev Port Cardiol, 32 (2013), pp. 981-986
Copyright © 2017. Sociedade Portuguesa de Cardiologia
Revista Portuguesa de Cardiologia
Opções de artigo
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Ao assinalar que é «Profissional de Saúde», declara conhecer e aceitar que a responsável pelo tratamento dos dados pessoais dos utilizadores da página de internet da Revista Portuguesa de Cardiologia (RPC), é esta entidade, com sede no Campo Grande, n.º 28, 13.º, 1700-093 Lisboa, com os telefones 217 970 685 e 217 817 630, fax 217 931 095 e com o endereço de correio eletrónico Declaro para todos os fins, que assumo inteira responsabilidade pela veracidade e exatidão da afirmação aqui fornecida.